{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:50:38Z","timestamp":1768546238585,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[1999,4]]},"DOI":"10.4065\/74.4.371","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:16:10Z","timestamp":1232759770000},"page":"371-375","source":"Crossref","is-referenced-by-count":45,"title":["Constrictive Pericarditis and Pleuropulmonary Disease Linked to Ergot Dopamine Agonist Therapy (Cabergoline) for Parkinson's Disease"],"prefix":"10.4065","volume":"74","author":[{"given":"Lieng H.","family":"Ling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Eric","family":"Ahlskog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Munger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew H.","family":"Limper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae K.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/74.4.371_bib1","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1212\/WNL.43.10.1981","article-title":"Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa\/carbidopa","volume":"43","author":"Lieberman","year":"1993","journal-title":"Neurology"},{"key":"10.4065\/74.4.371_bib2","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/archneur.1994.00540240080020","article-title":"Fluctuating Parkinson's disease; treatment with the long acting dopamine agonist cabergoline","volume":"51","author":"Ahlskog","year":"1994","journal-title":"Arch Neurol"},{"key":"10.4065\/74.4.371_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00002826-199619030-00002","article-title":"Adjunctive cabergoline therapy of Parkinson's disease; comparison with placebo and assessment of dose responses and duration of effect","volume":"19","author":"Ahlskog","year":"1996","journal-title":"Clin Neuropharmacol"},{"key":"10.4065\/74.4.371_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(81)90150-1","article-title":"Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease [letter]","volume":"1","author":"Rinne","year":"1981","journal-title":"Lancet"},{"key":"10.4065\/74.4.371_bib5","first-page":"35","article-title":"Pleuropulmonary reactions in patients on bromocriptine treatment","volume":"68","author":"Tornling","year":"1986","journal-title":"Eur J Respir Dis"},{"key":"10.4065\/74.4.371_bib6","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/archinte.1988.00380100089019","article-title":"Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease","volume":"148","author":"McElvaney","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.4065\/74.4.371_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.410300416","article-title":"Pleuropulmonary disease associated with dopamine agonist therapy","volume":"30","author":"Bhatt","year":"1991","journal-title":"Ann Neurol"},{"key":"10.4065\/74.4.371_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1183\/09031936.93.05020263","article-title":"Pleuropulmonary changes during treatment of Parkinson's disease with a long-acting ergot derivative, cabergoline","volume":"5","author":"Frans","year":"1992","journal-title":"Eur Respir J"},{"key":"10.4065\/74.4.371_bib9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1212\/WNL.43.3_Part_1.613","article-title":"Controlled study of the anti-parkinsonian activity and tolerability of cabergoline","volume":"43","author":"Hutton","year":"1993","journal-title":"Neurology"},{"key":"10.4065\/74.4.371_bib10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1210\/jcem-69-4-725","article-title":"Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyoerpro lactinemic patients","volume":"69","author":"Ciccarelli","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/74.4.371_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/mds.870110504","article-title":"Cabergoline in Parkinson's disease complicated by motor fluctuations","volume":"11","author":"Gemlnianl","year":"1996","journal-title":"Mov Disord"},{"key":"10.4065\/74.4.371_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.7326\/0003-4819-88-2-213","article-title":"Methysergide therapy and constrictive pericarditis","volume":"88","author":"Orlando","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.4065\/74.4.371_bib13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0735-1097(84)80342-3","article-title":"Simulation of acute myopericaritis by constrictive pericardial disease with endomyo-cardial fibrosis due to methysergide therapy","volume":"4","author":"Harbin","year":"1984","journal-title":"J Am Coll Cardiol"},{"key":"10.4065\/74.4.371_bib14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2214\/ajr.138.3.503","article-title":"Postpericardiotomy syndrome","volume":"138","author":"Kaminsky","year":"1982","journal-title":"AJR Am J Roentgenol"},{"key":"10.4065\/74.4.371_bib15","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/0002-8703(83)90663-4","article-title":"Gallium 67 scanning: a new diagnostic approach to the post-perieardiotomy syndrome","volume":"106","author":"Bufalino","year":"1983","journal-title":"Am Heart J"},{"key":"10.4065\/74.4.371_bib16","first-page":"147","article-title":"Pericardial diseases","volume":"Vol 2","author":"Lorell","year":"1997"},{"key":"10.4065\/74.4.371_bib17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/thx.41.4.328","article-title":"Bromocriptine induced pleuropulmonary fibrosis","volume":"41","author":"Wiggins","year":"1986","journal-title":"Thorax"},{"key":"10.4065\/74.4.371_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0002-8703(89)90273-1","article-title":"Constrictive pericarditis after cardiac surgery","volume":"118","author":"Killian","year":"1989","journal-title":"Am Heart J"},{"key":"10.4065\/74.4.371_bib19","first-page":"331","article-title":"Derrame pleural y pericarditis constrictiva secundarios al tratamiento con bromocriptina","volume":"6","author":"Saura","year":"1991","journal-title":"Neurologia"},{"key":"10.4065\/74.4.371_bib20","series-title":"Physicians' Desk Reference","first-page":"589","year":"1998"},{"issue":"Suppl A","key":"10.4065\/74.4.371_bib21","doi-asserted-by":"crossref","first-page":"32A","DOI":"10.1016\/S0735-1097(96)80319-6","article-title":"Clinical profile of constrictive pericarditis in the modern era: a survey of 135 cases [abstract]","volume":"27","author":"Ling","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.4065\/74.4.371_bib22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archinte.1989.00390020008002","article-title":"Bromocriptine and pleuropulmonary disease [editorial]","volume":"149","author":"Melmed","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.4065\/74.4.371_bib23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ana.410280429","article-title":"Cabergoline: a long acting dopamine agonist in Parkinsons disease [letter]","volume":"28","author":"Lera","year":"1990","journal-title":"Ann Neurol"},{"key":"10.4065\/74.4.371_bib24","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1212\/WNL.43.12.2587","article-title":"Cabergoline in Parkinson's disease: long-term follow-up","volume":"43","author":"Lera","year":"1993","journal-title":"Neurology"},{"key":"10.4065\/74.4.371_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/hrt.51.2.205","article-title":"Constrictive pericarditis as a complication of coronary artery bypass surgery","volume":"51","author":"Rlbeiro","year":"1984","journal-title":"Br Heart J"},{"key":"10.4065\/74.4.371_bib26","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0025-6196(12)60065-2","article-title":"Transient constrictive pericarditis: diagnosis by two-dimensional Doppler echocardiography","volume":"68","author":"Oh","year":"1993","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/74.4.371_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.2042-7158.1973.tb10037.x","article-title":"Effect of ergot drugs on central catecholamine neurons: evidence fora stimulation of central dopamine neurons","volume":"25","author":"Corrodl","year":"1973","journal-title":"J Pharm Pharmacol"},{"key":"10.4065\/74.4.371_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0306-3623(86)90011-X","article-title":"Selectivity of some ergot derivatives for 5-HT1 and 5-HT2 receptors of rat cerebral cortex","volume":"17","author":"Beart","year":"1986","journal-title":"Gen Pharmacol"},{"key":"10.4065\/74.4.371_bib29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1056\/NEJM196602172740701","article-title":"Fibrotic disorders associated with methysergide therapy for headache","volume":"274","author":"Graham","year":"1966","journal-title":"N Engl J Med"},{"key":"10.4065\/74.4.371_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000441-196707000-00001","article-title":"Cardiac and pulmonary fibrosis during methysergide therapy for headache","volume":"254","author":"Graham","year":"1967","journal-title":"Am J Med Sci"},{"issue":"Suppt 1","key":"10.4065\/74.4.371_bib31","first-page":"45","article-title":"FCE 21336","volume":"5","author":"Di Salle","year":"1982","journal-title":"a new ergoline derivative with a potent and longacting lowering effect on prolactin secretion in rats, J Endocrinol Invest"},{"key":"10.4065\/74.4.371_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.1979.tb01357.x","article-title":"The effects of dopamine. bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells","volume":"10","author":"Yeo","year":"1979","journal-title":"Ciin Endocrinol (Oxf)"},{"key":"10.4065\/74.4.371_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/jnnp.66.1.79","article-title":"Pericardial. retroperitoneal, and pleural fibrosis induced by pergolide","volume":"66","author":"Shaunak","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611644054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611644054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T12:22:29Z","timestamp":1709986949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611644054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1999,4]]}},"alternative-id":["S0025619611644054"],"URL":"https:\/\/doi.org\/10.4065\/74.4.371","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[1999,4]]}}}